InventionMed S.A. (WSE:INM)

InventionMed Statistics

Total Valuation

InventionMed has a market cap or net worth of PLN 29.71 million. The enterprise value is 32.38 million.

Market Cap	29.71M
Enterprise Value	32.38M

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

InventionMed has 202.79 million shares outstanding.

Current Share Class	201.79M
Shares Outstanding	202.79M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	5.61%
Owned by Institutions (%)	n/a
Float	113.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.80
PB Ratio	145.07
P/TBV Ratio	256.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.67
EV / Sales	16.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.10

Financial Position

The company has a current ratio of 0.08, with a Debt / Equity ratio of 13.07.

Current Ratio	0.08
Quick Ratio	0.08
Debt / Equity	13.07
Debt / EBITDA	n/a
Debt / FCF	-1.00
Interest Coverage	-1.02

Financial Efficiency

Return on equity (ROE) is -180.23% and return on invested capital (ROIC) is -31.23%.

Return on Equity (ROE)	-180.23%
Return on Assets (ROA)	-2.76%
Return on Invested Capital (ROIC)	-31.23%
Return on Capital Employed (ROCE)	-7.18%
Revenue Per Employee	401,392
Profits Per Employee	-746,717
Employee Count	5
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.75% in the last 52 weeks. The beta is 0.15, so InventionMed's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	-26.75%
50-Day Moving Average	0.15
200-Day Moving Average	0.18
Relative Strength Index (RSI)	41.47
Average Volume (20 Days)	126,133

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InventionMed had revenue of PLN 2.01 million and -3.73 million in losses. Loss per share was -0.02.

Revenue	2.01M
Gross Profit	1.75M
Operating Income	-1.70M
Pretax Income	-3.73M
Net Income	-3.73M
EBITDA	-841,474
EBIT	-1.70M
Loss Per Share	-0.02

Balance Sheet

The company has 6,230 in cash and 2.68 million in debt, giving a net cash position of -2.67 million or -0.01 per share.

Cash & Cash Equivalents	6,230
Total Debt	2.68M
Net Cash	-2.67M
Net Cash Per Share	-0.01
Equity (Book Value)	204,788
Book Value Per Share	0.00
Working Capital	-13.46M

Cash Flow

In the last 12 months, operating cash flow was -1.96 million and capital expenditures -716,805, giving a free cash flow of -2.67 million.

Operating Cash Flow	-1.96M
Capital Expenditures	-716,805
Free Cash Flow	-2.67M
FCF Per Share	-0.01

Margins

Gross margin is 86.99%, with operating and profit margins of -84.89% and -186.03%.

Gross Margin	86.99%
Operating Margin	-84.89%
Pretax Margin	-186.03%
Profit Margin	-186.03%
EBITDA Margin	-41.93%
EBIT Margin	-84.89%
FCF Margin	n/a

Dividends & Yields

InventionMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-12.57%
FCF Yield	-9.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 6, 2022. It was a forward split with a ratio of 4.

Last Split Date	Sep 6, 2022
Split Type	Forward
Split Ratio	4

Scores

InventionMed has an Altman Z-Score of -1.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.13
Piotroski F-Score	4